|
|
FDADocs 5/9/2008 | 0 (0) | 48 | 0 | 0 | English
SAMPLE NO.AFFIDAVIT (In-transit Sampling)STATE OF COUNTY OF55522 UINTAHUTAHBefore me, Sylvia A. Rogers , an employee of the Department of Health and Human Service... ... more>>
FDADocs 5/8/2008 | 0 (0) | 48 | 1 | 0 | English
Safety PageHow FDA reviews drug namesEditors??? note: According to a 1999 Institute of Medicine... column. The Food & Drug Administration has received approximately 18,000 reports of actual or potential ... more>>
FDADocs 5/9/2008 | 0 (0) | 47 | 2 | 0 | English
FDA Regulations and Recommendations for Failure InvestigationsHoi-may Wong, BS, MT(ACSP)SBB Blood and Plasma Branch Division of Blood Applications, FDA, CBER, OBRRFDA Workshop Licensure of ... more>>
FDADocs 5/9/2008 | 0 (0) | 46 | 0 | 0 | English
FDA Forum handheld Doppler safetyPage 1FDA Forum handheld Doppler safetyPage 2FDA Forum handheld Doppler safetyPage 3FDA Forum handheld Doppler safetyPage 4FDA ... more>>
FDADocs 5/9/2008 | 0 (0) | 46 | 0 | 0 | English
FDA Approved Labeling Text for NDA 21-717/S-005 & S-008 FINAL-Label-23-JAN-2004 PROVIGIL?? (modafinil) Tablets [C-IV] DESCRIPTION PROVIGIL (modafinil) is a wakefulness-promoting agent for oral ... more>>
FDADocs 5/9/2008 | 0 (0) | 46 | 0 | 0 | English
DEPARTMENT OF HEALTH & HUMAN SERVICESPublic Health ServiceFood and Drug Administration Rockville, MD 20857NDA 18-662/S046Hoffman-La Roche Inc. Attention: Joanna Wau... ... more>>
GovernmentDocs 5/4/2008 | 0 (0) | 45 | 0 | 0 | English
Guidance for Industry and FDA StaffGuidance Document for Vascular Prostheses 510(k) SubmissionsDocument issued on: November 1, 2000This document supercedes Guidance Document for Vascular ... more>>
FDADocs 5/8/2008 | 0 (0) | 44 | 0 | 0 | English
Safety PageTable 1.Med error reports to FDA show a mixed baghe medication errors staff in... Adverse Event Reporting System (AERS) database for all cases of medication errors. Since the FDA often ... more>>
GovernmentDocs 5/4/2008 | 0 (0) | 44 | 0 | 0 | English
Industry and FDA StaffDocument Issued on: November 2, 2007This document supersedes the... contact Chester T. Reynolds, 240-276-0157 or mailto:Chester.Reynolds@fda.hhs.govU.S. Department ... more>>
FDADocs 5/9/2008 | 0 (0) | 44 | 0 | 0 | English
Eric P. Bastings, MD, HFD-120 21-645 Myzan (MT100)Memorandum )Page 1 ofMEMORANDUMDEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administrat... ... more>>
FDADocs 5/9/2008 | 0 (0) | 44 | 1 | 0 | English
FDA DRUG AND DEVICE PRODUCT APPROVALSVolume 17 (1) January 1994Center for Drug Evaluation and Research *George R. Scott (301) 443-3910 Center for Biologics Evaluation and Research Joseph ... more>>
FDADocs 5/9/2008 | 0 (0) | 43 | 0 | 0 | English
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health ServiceDivision of Dermatologic and Dental Drug Products Office of Drug Evaluation III Center for Drug Evaluation and Research... ... more>>
FDADocs 5/5/2008 | 0 (0) | 43 | 1 | 0 | English
FDA Regulations and Recommendations for Failure InvestigationsHoi-may Wong, BS, MT(ACSP)SBB Blood and Plasma Branch Division of Blood Applications, FDA, CBER, OBRRFDA Workshop Licensure of ... more>>
GovernmentDocs 5/5/2008 | 0 (0) | 43 | 2 | 0 | English
Comparison Chart of FDA and EPA Good Laboratory Practice (GLP) Regulations and the OECD Principles of GLPDocument issued on: June 2004U.S. Department of Health and Human Services Food and Drug ... more>>
GovernmentDocs 5/5/2008 | 0 (0) | 43 | 0 | 0 | English
NDA 20-895/S-003Pfizer Inc Attention: Rita Wittich Director, Regulatory Affairs 235 East 42nd Street New York, NY 10017Dear Ms. Wittich: Please refer to your supplemental n... ... more>>
| | | |
| results / page 15/25/50 |
Page: 4 of 33
|
4...
|
|